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Abstract
Background: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood 
samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status 
using polymerase chain reaction (PCR) quantification (infected cell % of peripheral mononuclear cells) and Southern 
blotting hybridization (SBH) methods.
Results: The present study disclosed extremely high VL with highly dense smears with or without oligoclonal bands in 
SBH. A high VL of 10% or more was observed in 16 (43.2%) of a total of 33 samples (one of 13 asymptomatic carriers, 8 
of 12 symptomatic carriers, and 7 of 8 patients with lymphoma-type ATL without circulating ATL cells). In particular, an 
extremely high VL of 50% or more was limited to symptomatic carriers whose band findings always contained at least 
dense smears derived from polyclonally expanded cells infected with HTLV-1. Sequential samples revealed that the VL 
value was synchronized with the presence or absence of dense smears, and declined at the same time as disappearing 
dense smears. Dense smears transiently emerged at the active stage of the underlying disease. After disappearance of 
the smears, several clonal bands became visible and were persistently retained, explaining the process by which the 
clonality of HTLV-1-infected cells is established. The cases with only oligoclonal bands tended to maintain a stable VL of 
around 20% for a long time. Two of such cases developed ATL 4 and 3.5 years later, suggesting that a high VL with 
oligoclonal bands may be a predisposing risk to ATL.
Conclusion: The main contributor to extremely high VL seems to be transient emergence of dense smears detected 
by the sensitivity level of SBH, corresponding to polyclonal expansion of HTLV-1-infected cells including abundant 
small clones. Major clones retained after disappearance of dense smears stably persist and acquire various malignant 
characteristics step by step.
Background
Human T-cell leukemia virus type-1 (HTLV-1) is thought
to infect mainly CD4 T-cells, and to cause T-cell malig-
nancy adult T-cell leukemia (ATL) after a long latency, a
degenerative nervous disorder of HTLV-1-associated
myelopathy (HAM), and so on [1,2]. During the clinically
asymptomatic period preceding the diseases, the HTLV-
1-infected cell number is low, at about less than 2 - 3% per
100 blood mononuclear cells (MNC). Therefore, infected
cells in asymptomatic (healthy) carriers are considered to
proliferate polyclonally because the provirus integrates at
a  r a n d o m  s i t e  [ 3 ] .  R e c e n t  w o r k  u s i n g  r e a l - t i m e  p o l y -
merase chain reaction (PCR) quantification for HTLV-1
provirus (proviral load: VL) and inverse PCR indicates
that clonal expansion of HTLV-1-infected cells is impor-
tant for the maintenance of infection [4-6]. Interestingly,
the proviral integration sites in genomic DNA in asymp-
tomatic and symptomatic carriers without ATL is either
random or constant, implying the difference in clonality
detected by Southern blotting hybridization (SBH) [7,8].
Thus, high VL corresponding to an increased number of
polyclonal or monoclonal infected cells is one of the key
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events in HTLV-1-associated pathology. Therefore, a
h i g h  V L  wi t h  c l o n a l  e x p a n s i o n  h a s  po t e n t i a l  a s  a  b i o -
marker to predict patients predisposed to ATL or HAM
[9,10]. On the other hand, HTLV-1-infected individuals
who are complicated by opportunistic infections, such as
parasites, mycosis, viruses and some bacteria, and abnor-
mal immunity due to aging are known to show an
increased proviral load with polyclonal expansion [11-
13]. This condition associated with polyclonal expansion
of the infected cells was considered to be the intermedi-
ate state prior to progression to ATL [14], but the patho-
logical and clinical correlation between clonality and level
of VL is not fully understood. Recently, we have had fre-
quent opportunities to see unusual or indeterminate ATL
patients or carriers with high VL with discrete band(s) in
SBH, but no circulating ATL cells, especially among the
elderly.
Accordingly, to address what kind of clonal infected
cells contribute to high VL, and clarify unusual ATL or
carrier states, we simultaneously analyzed HTLV-1 provi-
ral load and SBH status using the same blood samples. In
contrast to the maintenance of stable VL in asymptomatic
carriers with no-bands or only faint discrete bands, the
VL in symptomatic carriers with complications unrelated
HTLV-1 tended to have high VL with dense smears with/
without discrete band(s), consisting of mainly polyclonal
expansion and partial oligoclonal expansion of the
infected cells.
Results
Sample features and SBH band status
The median age of the 29 subjects who donated periph-
eral blood was 66 years old (range, 49-81). No circulating
ATL cells were found morphologically or immunopheno-
tyically in any samples, including 8 samples of lym-
phoma-type ATL employed as a control. Subsequently, all
33 samples were divided into 3 groups; 13 asymptomatic
healthy carriers (median age, 60), 12 symptomatic carri-
ers (median age, 68) with complications unrelated to
HTLV-1 such as infectious diseases (Strongyloides,
hepatic disorders due to HBV and HCV, chronic pneu-
monitis or bronchitis) and immune-disorders (Crow-
Fukase syndrome, RA, and chronic eczema, and reactive
unknown adenitis) and 8 patients with lymphoma-type
ATL. The distribution of SBH band patterns in each
group is summarized in Table 1 and the median proviral
loads of the no-band, dense smears and clonal band
groups were 2.0% (range, 0.1 - 9.0), 27.9% (5.0-97.4), and
20.1% (8.3-74.3), respectively, as shown in Table 1 and
Figure 1.
Characteristic band patterns in samples with high VL
Although SBH in asymptomatic carriers gave no clonal
band with or without very faint Smears, SBH in some
symptomatic carriers gave characteristic band patterns,
as shown in Figure 2. Those were mainly a mixture type
of dense smears and discrete oligoclonal bands in symp-
tomatic carriers with high VL, such as cases 1 (VL, 97%),
3 (74%), 4 (57%), and 5 (21%). On the other hand, in sam-
ples from lymphoma-type ATL, the mixture type was
detected in only case 10 and the clonal band type was
detected in case 10 to 15. For all sample tested, the rela-
tionship between VL and band status is depicted in Fig-
ure 3, showing no-band or vague smears in all but one of
the healthy carriers, either dense smears or a mixture of
dense smears and oligoclonal bands (open circle+S:+S)
in symptomatic carriers and mainly discrete clonal band
in patients with lymphoma-type ATL. In particular, an
extremely high VL of 50% or more was limited to symp-
tomatic carriers whose band findings always contained at
least dense smears. Moreover, as shown in Figure 4,
sequential samples disclosed that a higher VL value was
synchronized with the transient emergence of dense
smears, and declined at the same time as disappearing
dense smears. After that, several discrete bands became
visible and were persistently retained.
Clinical features in symptomatic carriers and patients with 
lymphoma-type ATL
Clinico-hematological features in 15 cases with a high VL
of 10% or more and distinctive band patterns are summa-
rized in Additional file 1. Of 8 symptomatic carriers,
complicated disorders were mainly associated with
abnormal immunity or non-bacterial pathogens. Two of 8
Figure 1 The distribution of HTLV-1 proviral load (VL) per 100 
blood mononuclear cells (MNC) in each sample among the no-
band, dense smears and clonal band(s) groups classified accord-
ing to Southern blotting (SBH) status. Short bar; median VL.
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symptomatic carriers developed ATL, case 3 in 4 years
later and case 5 in 3.5 years later, respectively. For lym-
phoma-type ATL, SBH for Lymph node (LN) suspension
cells gave positive results in 5 of 6 samples tested. The
band size was different in case 11 and was accordant in
case 14 between PB and LN, while the other band profiles
were very similar to those of symptomatic carriers; they
were like a relic of the symptomatic carriers' past.
Discussion
Recent studies including our previous studies [13,15] sug-
gest that VL in asymptomatic carriers may be approxi-
mately one copy per 25 to 1000 MNC. Even in patients
with HAM whose VL are known to be high, the VL may
be as high as one copy per 10 to 100 MNC. Therefore, we
defined a VL of 10% or more per 100 MNC as unusually
high.
In the present study, we found that the results of VL
and SBH status in healthy carriers were the same as those
of the past reports, while there was an extremely high VL
with a characteristic band status of high dense smears
with or without clonal bands in elderly symptomatic car-
riers. A VL of 10% or more (range, 10 to 97.4%) was
detected in 16 (43.5%) of all samples, 1 (6.3%)/16 asymp-
tomatic healthy carriers, 8 (61.5%)/13 symptomatic carri-
ers unrelated to HTLV-1 and 7(87.5%)/8 patients with
lymphoma-type ATL without circulating ATL cells. On
the other hand, in SBH analysis, no visible aberrant bands
were detectable in low VL samples with less than 10%. All
but one of the asymptomatic carriers (mean age; 60) were
of this pattern. In contrast, the high VL samples with 10%
or more displayed distinctive band patterns accompanied
by dense smears with or without discrete clonal band(s),
indicating that an increase in polyclonally infected-cells
corresponding to dense smears contributed to a high VL.
As triggering factors for HTLV-1-infected cells, various
microbes and abnormal immunity due to aging in symp-
tomatic carriers were suspected. Furthermore, the obser-
vations from sequential samples also support the
contribution of dense smears to the elevation of VL. This
helps explain the process by which the clonality of HTLV-
1-infected cells is established after the disappearance of
dense smears.
It is now recognized that clonal expansion of HTLV-1-
infected cells is the norm in nonmalignant disease [11]. In
the present study, of 13 asymptomatic and 12 symptom-
atic carriers, the incidence of clonality was 24.0% (6/25
cases), of which 4 cases were accompanied by dense
smears and maintained a higher VL. In other word, this
suggests that polyclonal expansion, rather than oligoclo-
nal expansion, contributes to a high VL. The contribution
of clonal expansion to the elevation of VL in carriers is
thought to be small because VL in HAM patients is gen-
e r a l l y  r e p o r t e d  t o  b e  a r o u n d  1 0 %  o n  a v e r a g e .  I n  f a c t ,
Furukawa et al. [8] reported a high frequency of clonality
of 20% in HAM patients and 16% in carriers in families of
HAM patients, while the VL was at most 10 to 20% in
general. On the other hand, patients co-infected with
Table 1: The distribution of HTLV-1 SBH band status in samples without circulating ATL cells among three HTLV-1-
seropsitive groups, asymptomatic (healthy), symptomatic carriers with HTLV-1-unrelated disorders and patients with 
lymphoma type ATL.
SBH
HTLV-1 
seropositive 
persons
No. no-band* dense smears clonal band(s) total
asymptomatic 
(healthy)
13 11 (84.6%) 2 (15.4%) 0 (0%) 100%
symptomatic, 
(complication 
unrelated to 
HTLV-1)
12 4 (33.3%) 2 (16.7%) 6(4)**(50.0%) 100%
patients with lym. 
type ATL***
8 1 (12.5%) 3 (37.5%) 4 (1)**(50.0%) 100%
total 33 16 (48.5%) 7(21.2%) 10 (5)**(30.3%) 100%
*: no-band with or without vague smears
**: aberrant bands showing broad bands
***: patients with lym. Type ATL was defined as cases with no morphological and immunophenotypical abnormal lymphocytes
(): the number of cases with co-existence of clonal band(s) and dense smear bandsSasaki et al. Virology Journal 2010, 7:81
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strongyloidosis and HTLV-1 have been reported to har-
bor a higher VL of around 50% with a high incidence
(39%) of clonality [16,17]. The relation between VL and
clonality is controversial [11,12] because the decision
regarding clonality depends on the sensitivity of the
method.
Taken together, our study supports the idea that
extremely high VL mainly results from polyclonal expan-
sion of HTLV-1 infected cells at the sensitive level of SBH.
In samples from patients with lymphoma-type ATL
without ATL cells, a clonal band(s) was demonstrated in
4 of the 8 patients. Band size between blood and lymph
nodes was the same in two of the 4 cases, but no circulat-
ing A TL was found. Other aberrant bands, as summa-
rized in Additional file 1, were also observed. Such a band
profile in ATL (lymphoma-type) appears to be looks a
relic of a symptomatic carriers' past, indicating that high
VL  wi t h  a be rr a n t  ba n ds  c o u l d  bec o m e  a  b i o m a r k e r  t o
Figure 2 Representative band patterns by SBH analysis in high VL carriers with dense smears, aberrant-bands with/without faint sharp 
band(s). E & P; EcoR1 and Pst-1 digestion, *, **, ***; internal bands after Pst-1 digestion, ￿; clonal band(s), PB; peripheral blood, LN; lymph node. Case 
1: Typical dense smeared band, case 3: probably two bands within dense smeared bands in March, 2006, and clear multi-bands in September, 2007. 
Cases 4, 5, 6, 7, 8, and 10; two or more vague clonal band(s). Case 11; different band sizes between peripheral blood (PB) and lymph nodes (LN), Cases 
12 and 13; two clonal bands and an atypical broad band, Case 14; the same band size for LN and blood.
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predict the development of ATL. Indeed, cases 3 and 5
developed smoldering ATL after 4 years and acute ATL
after 3 years, respectively. A conceptual scheme is pre-
sented in Figure 5, which shows the biological signifi-
cance of the fluctuation in a high VL with either dense
smears or oligoclonal bands durig multi-step leukomo-
genesis as a stone corner of dense smear emergence.
Conclusion
Focusing on not only discrete clonal band(s), but also
aberrant smears, it is noteworthy that the emergence of
dense smears equivalent to polyclonal expansion of
infected cells mainly contributed to a high level VL. How-
ever, it is reasonable that a high VL does not consist of
only polyclonally expanded infected cells, but included
abundant small clones in the cell population, because of
sensitivity in SBH. SBH for HTLV-1 could evaluate or
monitor the clinical clonal status of HTLV-1-infected
cells. Clinically, the distinctive profile of high VL and
aberrant band status is expected to monitor or predict
some events caused by HTLV-1.
Figure 3 A comparison between the level of VL and SBH status 
among healthy asymptomatic carriers, symptomatic carriers with 
complications unrelated to HTLV-1, and patients with lymphoma 
type ATL. Gray diamond; no-band, gray circle; vague to faint smears, 
solid circle; dense smears, open circle; clonal band, +S: mixture band of 
dense smears and conal bands.
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Materials and methods
Samples
Samples were collected from our ATL clinical laboratory,
consisting of 16 asymptomatic and 13 symptomatic carri-
ers and 8 patients with lymphoma-type ATL as a control
because this type of ATL has no circulating ATL cells. A
total of 37 samples were seropositive for HTLV-1 and
undetectable morphologically and immunophenotypi-
cally for ATL cells, indicating all samples had no evidence
of circulating ATL cells.
Serologic and genomic assays for HTLV-1
Anti-HTLV-1 antibodies were detected by chemilumi-
nescent enzyme immunoassay (Fuji Rebio, Tokyo, Japan).
High-molecular-weight DNA was extracted from blood
mononuclear cells (MNCs) using a QIAmp DNA Blood
Mini kit (Qiagen GmbH, Hilden, Germany). VL was
quantified by LightCycler Technology (Roche Diagnostics
KK, Tokyo, Japan) using hydro-probes and previously
described primers [15], with β-globin as an internal con-
trol. The PCR methodology was monitored by determin-
ing the amount of β-globin DNA required to generate
10,000 copies per 5,000 MNC. We assumed that one
infected cell harbored one provirus, and the number of
infected cells was therefore estimated to be the same as
the proviral copy number and was expressed per 100
MNC (% or load).
Clonal assay by SBH
SBH analysis was performed as described previously
[18,19], using mixture probes covering the total region of
the provirus digoxigenined and the restriction enzymes
EcoR1 and Pst-1. There are four Pst-1 sites but no EcoR1
site within the proviral sequence. Accordingly, if EcoR1-
digestion gave no-band or faint smears and Pst-1-diges-
tion gave only three internal bands, the sample was con-
sidered to be negative for clonal expansion. When
discernible discrete band(s) in the EcoR1-digestion mem-
brane or one or two external band(s) in addition to three
internal bands in the Pst-1-digestion membrane were vis-
ible, the sample was considered to harbor clonal inte-
grated provirus, implying that the infected cells had
expanded clonally. The results of SBH analysis were clas-
sified into three patterns; no-band, dense smears and one
or more discrete band(s). "Dense" smears were assumed
to be distinct from those of common carriers (3 fold<
smear density relative to background lane densitiy). The
detection sensitivity for clonally infected cells in the SBH
assay was 3-5% [18]. The sensitivity was monitored in
each blotting membrane using 3-5% clonal cells from the
ST1 ATL cell line.
Statistics
Data were analyzed using Mann-Whitney or Chi-squared
tests. Statistical significance was set at p < 0.05.
Figure 5 Conceptual scheme of the fluctuations in the total proviral load (VL) in peripheral blood with no circulating abnormal cells during 
multi-step leukemogenesis. VL is low in the early phase of the latent period, during which infected cells consist of clones with a small population. 
At some time point, some clones may become large enough to be detected as bands by Southern blotting. Peak A corresponds to smears detected 
as polyclonal expansion by SBH, and then peaks B, C and D appear with oligoclonal bands.
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reaction.
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Additional file 1 Summary of the main clinical and laboratory data in 
seropsitive individuals with high VL and aberrant band patterns in 
SBH, and outcome in Dec 2008. Two cases (#3 and 5) among 8 
advanced carriers (cases 1 to 8) developed ATL 4 and 3 years later. 
Cases 1, 2 and 15: High VL carriers with polyclonal expansion. Cases 3-14; 
aberrant bands mainly with faint multiple clonal bands, Final diagnosis was 
based on the integrated findings of an LN SBH test and clinico-pathological 
examinations. ALCL; anaplastic large cell lymphoma, DLBCL; diffuse large 
cell B-cell lymphoma, (-) or (+); negative or positive clonal band, S; smear, B; 
band, NT: not tested, Dx: diagnosis, *: indeterminate for clonal band, **: 
pathological diagnosis was indeterminate. For the other abbreviations; refer 
to the context.
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